Literature DB >> 19483161

Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages.

Massimo Gentile, Giovanna Cutrona, Antonino Neri, Stefano Molica, Manlio Ferrarini, Fortunato Morabito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19483161      PMCID： PMC2688585          DOI： 10.3324/haematol.2009.005561

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Induction of beta-2-microglobulin release in vitro by chronic lymphocytic leukaemia cells: relation to total protein synthesis.

Authors:  J Vilpo; L Vilpo; M Hurme; P Vuorinen
Journal:  Leuk Res       Date:  1999-10       Impact factor: 3.156

2.  Clinical significance of CD38 expression in chronic lymphocytic leukemia.

Authors:  G Del Poeta; L Maurillo; A Venditti; F Buccisano; A M Epiceno; G Capelli; A Tamburini; G Suppo; A Battaglia; M I Del Principe; B Del Moro; M Masi; S Amadori
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

3.  CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.

Authors:  Davide Rossi; Antonella Zucchetto; Francesca Maria Rossi; Daniela Capello; Michaela Cerri; Clara Deambrogi; Stefania Cresta; Silvia Rasi; Lorenzo De Paoli; Chiara Lobetti Bodoni; Pietro Bulian; Giovanni Del Poeta; Marco Ladetto; Valter Gattei; Gianluca Gaidano
Journal:  Haematologica       Date:  2008-07-18       Impact factor: 9.941

4.  Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.

Authors:  William G Wierda; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Francis Giles; Farhad Ravandi; Susan Lerner; Hagop Kantarjian; Michael Keating
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

Review 5.  New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemia.

Authors:  Massimo Gentile; Francesca Romana Mauro; Anna Guarini; Robin Foà
Journal:  Curr Opin Oncol       Date:  2005-11       Impact factor: 3.645

6.  Beta 2-microglobulin in chronic lymphocytic leukaemia.

Authors:  B Simonsson; L Wibell; K Nilsson
Journal:  Scand J Haematol       Date:  1980-02
  6 in total
  14 in total

1.  Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.

Authors:  Inger Lise Gade; Signe Juul Riddersholm; Ilse Christiansen; Annika Rewes; Mikael Frederiksen; Lisbeth Enggaard; Christian Bjørn Poulsen; Olav Jonas Bergmann; Dorte Balle Gillström; Robert Schou Pedersen; Linda Nielsen; Helle Højmark Eriksen; Christian Torp-Pedersen; Søren Risom Kristensen; Marianne Tang Severinsen
Journal:  Blood Adv       Date:  2018-11-13

2.  Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.

Authors:  Natali Pflug; Jasmin Bahlo; Tait D Shanafelt; Barbara F Eichhorst; Manuela A Bergmann; Thomas Elter; Kathrin Bauer; Gebhart Malchau; Kari G Rabe; Stephan Stilgenbauer; Hartmut Döhner; Ulrich Jäger; Michael J Eckart; Georg Hopfinger; Raymonde Busch; Anna-Maria Fink; Clemens-Martin Wendtner; Kirsten Fischer; Neil E Kay; Michael Hallek
Journal:  Blood       Date:  2014-05-05       Impact factor: 22.113

3.  Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.

Authors:  Philip A Thompson; Francesco Stingo; Michael J Keating; William G Wierda; Susan M O'Brien; Zeev Estrov; Celina Ledesma; Katayoun Rezvani; Muzaffar Qazilbash; Nina Shah; Simrit Parmar; Uday Popat; Paolo Anderlini; Nieto Yago; Stefan O Ciurea; Partow Kebriaei; Richard Champlin; Elizabeth J Shpall; Chitra M Hosing
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

4.  Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903).

Authors:  Sanford Kempin; Zhuoxin Sun; Neil E Kay; Elisabeth M Paietta; Joseph J Mazza; Rhett P Ketterling; Olga Frankfurt; David F Claxton; Joel N Saltzman; Gordan Srkalovic; Natalie S Callander; Gerald Gross; Martin S Tallman
Journal:  Acta Haematol       Date:  2019-07-23       Impact factor: 2.195

Review 5.  Prognostic factors in chronic lymphocytic leukemia-what do we need to know?

Authors:  Paula Cramer; Michael Hallek
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

Review 6.  Chronic lymphocytic leukemia: inception to cure: are we there?

Authors:  Deepesh P Lad; Pankaj Malhotra; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-09       Impact factor: 0.900

7.  β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia.

Authors:  Philip A Thompson; Susan M O'Brien; Lianchun Xiao; Xuemei Wang; Jan A Burger; Nitin Jain; Alessandra Ferrajoli; Zeev Estrov; Michael J Keating; William G Wierda
Journal:  Cancer       Date:  2015-11-20       Impact factor: 6.860

8.  Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia.

Authors:  A M Hurtado; T-H Chen-Liang; B Przychodzen; C Hamedi; J Muñoz-Ballester; B Dienes; M D García-Malo; A I Antón; F de Arriba; R Teruel-Montoya; F J Ortuño; V Vicente; J P Maciejewski; A Jerez
Journal:  Blood Cancer J       Date:  2015-08-28       Impact factor: 11.037

9.  TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases.

Authors:  İbrahim Kulaç; Çetin Demir; Yahya Büyükaşık; Tezer Kutluk; Ayşegül Üner
Journal:  Turk J Haematol       Date:  2016-05-12       Impact factor: 1.831

10.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.